A positive tuberculosis (TB) skin test can look different depending on your risk factors. Learn risk factors to consider and what a positive test may look like.

Although tuberculosis is uncommon in the U.S., ... had planned to utilize a secondary patent to extend their control of it until the end of 2027, advocates say. ...

Now, the group is turning attention to Otsuka’s TB drug delamanid and its secondary patents, it said in a recent statement. Johnson & Johnson Sirturo bedaquiline Tuberculosis Pharma.

Treating latent TB will prevent them from having active or secondary TB. Treatment for latent TB is quite different from that of active TB. So, you must be distinctively tested and detected.

What is TB? Tuberculosis, also known as TB, is a bacterial infection that primarily affects a person's lungs. Its symptoms vary widely depending on how the slow-growing mycobacterium that causes ...

T he patent on the tuberculosis drug bedaquiline expires today (July 18). But while its manufacturer, Johnson & Johnson, intends to use secondary patents to extend its exclusive right to sell the ...

For example, Tisile and fellow TB survivor Nandita Venkatesan filed a legal challenge against J&J in 2019 to prevent the company from enforcing its secondary patent over bedaquiline in India.